Key Facts and Data Points
- No‑fault liability principle ordered for Covid‑19 vaccine injury compensation.
- Victims/families need not prove negligence of manufacturers or the State.
- Incidence of serious clotting disorder cited: 0.001 per 1 lakh doses.
- Existing Indian no‑fault scheme: Motor Vehicle Accident compensation.
- International models: Australia, United Kingdom, Japan have similar vaccine injury schemes.
- Rare serious adverse events:
- Myocarditis/Pericarditis – linked to mRNA vaccines (Pfizer‑BioNTech, Moderna), mainly in adolescent/young adult males after the second dose.
- Thrombosis with Thrombocytopenia Syndrome (TTS) – linked to viral‑vector vaccines (AstraZeneca, Johnson & Johnson).
- Compensation amount (from earlier SC direction, 2021): Rs 50,000 per Covid‑19 death payable from State Disaster Response Fund.
Background and Context
- The Covid‑19 vaccination drive in India was a state‑led public‑health intervention and, while officially voluntary, effectively became mandatory through administrative restrictions.
- Prior Supreme Court judgments:
- Gaurav Kumar Bansal vs Union of India (2021) – directed NDMA to recommend ex‑gratia assistance for Covid‑19 deaths.
- Jacob Puliyel vs Union of India (2022) – upheld vaccine approval process and affirmed bodily integrity under Article 21.
- Existing Adverse Events Following Immunisation (AEFI) committees monitor vaccine safety but were deemed insufficient without a compensation mechanism.
Significance for India / Governance / Policy
- Constitutional duty: Article 21 (right to life & health) imposes a positive obligation on the State to support victims of rare vaccine injuries.
- Equality principle: Article 14 prevents disparate outcomes from multiple individual litigations.
- Establishes a uniform, streamlined red‑ressal mechanism, enhancing public confidence in vaccination programmes.
- Aligns India with global best practices, potentially influencing future vaccine injury policies (e.g., for emerging diseases).
Related Constitutional / Legal Provisions
- Article 21 – Right to life includes the right to health; mandates State’s proactive role.
- Article 14 – Equality before law; prevents arbitrary differential treatment.
- Motor Vehicles Act, 1988 – Provides a domestic precedent for no‑fault compensation.
- Consumer Protection Act, 2019 – Though not directly applied, underscores the need for consumer redressal mechanisms.
International Perspective
- Australia – National Vaccine Injury Compensation Scheme (NVICS).
- United Kingdom – Vaccine Damage Payment Scheme.
- Japan – Vaccine Injury Compensation System.
- These schemes compensate victims without establishing fault, mirroring the SC’s directive.
Frequently Asked Questions (FAQs)
- What is “no‑fault liability”?
- Compensation without the need to prove negligence or intentional wrongdoing.
- Which constitutional articles were cited?
- Articles 21 (Right to Life & Health) and 14 (Equality).
- What are the two rare serious adverse events?
- Myocarditis/Pericarditis (mRNA vaccines) and Thrombosis with Thrombocytopenia Syndrome (TTS) (viral‑vector vaccines).
Relevance for UPSC Exams
- Prelims: Factual recall of the SC order, constitutional articles, and international models.
- Mains: Analytical discussion on State’s positive obligations, policy design, and comparison with global schemes.
Prepared for UPSC Civil Services Examination aspirants.